14
Participants
Start Date
November 18, 2022
Primary Completion Date
September 18, 2023
Study Completion Date
October 20, 2023
Presendin
Presendin is supplied as 2 parts, one vial consisting of a drug part (white or greyish white powder in a clear vial) and one pre-filled syringe containing the diluent part (colourless liquid). The drug part is suspended in the diluent part solution and administered SC as a suspension.
Placebo
Placebo is supplied as 2 parts (visually identical to the Presendin vial and pre-filled diluent syringe). The drug part will exclude the active pharmaceutical ingredient (exenatide acetate) and the diluent part will be the same as the active treatment diluent. The drug part is suspended in the diluent part solution and administered SC as a suspension.
Sydney Eye Hospital, Sydney
Liverpool Hospital, Liverpool
Alfred Health - The Alfred Centre, Melbourne
Vision SA, Kent Town
New York Eye and Ear Infirmary of Mount Sinai, New York
University of Miami Leonard M. Miller School of Medicine (UMMSM) - Bascom Palmer Eye Institute, Miami
Vanderbilt Eye Institute, Nashville
University Hospital Muenster, Department Ophthalmology Clinical Trials in Ophthalmology (CTO), Münster
University Hospital Bonn, Bonn
Universitaetsmedizin Mainz, Mainz
University of Minnesota Health, Minneapolis
The University of Texas Southwestern Medical Center, Dallas
Neuro-Eye Clinical Trials, Inc, Houston
Universitätsklinikum Freiburg, Freiburg im Breisgau
UCHealth Sue Anschutz-Rodgers Eye Center - Anschutz Medical Campus, Aurora
Hadassah Medical Center - Ein Karem, Jerusalem
Pade Medical Center (Poriya), Tiberias
Rambam Medical Center, Haifa
Bnai Zion Medical Center, Haifa
The Edith Wolfson Medical Center, Holon
Shaare Zedek Medical Center, Jerusalem
New Zealand Clinical Research (Aukland), Auckland
University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital Birmingham, Birmingham
Guy's and St Thomas' NHS Foundation Trust, London
Lead Sponsor
Collaborators (1)
Premier Research Group plc
UNKNOWN
University Hospital Birmingham
OTHER
University of Iowa
OTHER
Invex Therapeutics Ltd.
INDUSTRY